Date of publication: April 30, 2021 Objectives: Evidence Summary: Use of Rapid Antigen Test Kits for the Diagnosis of COVID-19 HTAC Recommendation Review:
Janssen Ad26.COV2.S (COVID-19) Vaccine for the Prevention of COVID-19
Date of publication: April 30, 2021 Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report presents all currently available evidence considered in the assessment of COVID-19 Vaccine Janssen. This assessment follows the continue reading : Janssen Ad26.COV2.S (COVID-19) Vaccine for the Prevention of COVID-19
Sputnik V Gam-COVID-Vac COVID-19 Vaccine for the Prevention of COVID-19
Date of publication: April 12, 2021 Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report presents all currently available evidence considered in the assessment of COVID-19 Vaccine Gamaleya. This assessment follows the continue reading : Sputnik V Gam-COVID-Vac COVID-19 Vaccine for the Prevention of COVID-19
SARS-CoV-2 Vaccine (Vero Cell), Inactivated [CoronaVac] for the prevention of COVID-19
Date of publication: April 09, 2021 Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report presents all currently available evidence considered in the assessment of COVID-19 Vaccine CoronaVac. This assessment follows the continue reading : SARS-CoV-2 Vaccine (Vero Cell), Inactivated [CoronaVac] for the prevention of COVID-19
Effectiveness and Safety of Pazopanib in the Management of Metastatic Soft Tissue Sarcoma Post-Chemotherapy
Evidence Summary: effectiveness and safety of pazopanib in the management of metastatic soft tissue sarcoma post-chemotherapy